Identification of parathyroid by intra-operative real-time autofluorescence imaging: a prospective randomized controlled study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039455

Enrollment

Unknown

Registered

2020-10-28

Start date

2020-11-05

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Cancer

Interventions

Autofluorescence imaging:With fluorescence imaging eye-glass

Observation:Conventional surgery

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patient's age ranges from 18-70 years; 2.Malignant thyroid cancer diagnosed or suspected; 3.Patien is eligible for endoscopic assisted(modified Miccoli incision) and/or total endoscopic thyroidectomy; 4.Patient is able and willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Patient with concurrent parathyroid diseases (hyperparathyroidism or hypoparathyroidism); 2.Patient with abnormal serum calcium level; 3.Intraoperative frozen section indicating benign thyroid disease; 4.Thyroid gland could not be removed; 5.Emergency situations lead to the termination of the operation.

Design outcomes

Primary

Measure	Time frame
Parathyroid gland(s) inadvertently resected rate;	—

Secondary

Measure	Time frame
Parathyroid gland(s) identification rate (in situ);Parathyroid gland(s) identification rate (isolated);Hypoparathyroidism rate;	—

Countries

China

Contacts

Public ContactJida Chen

Affiliated Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine

3305052@zju.edu.cn+86 571-86002170

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026